"Phase I/II trial of paclitaxel by 1-hour infusion, carboplatin, and gemcitabine in the treatment of patients with advanced nonsmall cell lung carcinoma †" by John D. Hainsworth

Article

Phase I/II trial of paclitaxel by 1-hour infusion, carboplatin, and gemcitabine in the treatment of patients with advanced nonsmall cell lung carcinoma †

Cancer (1999)

John D. Hainsworth, Sarah Cannon Research Institute
Howard A. Burris, Sarah Cannon Research Institute
Joan B. Erland
Lisa H. Morrissey
Anthony A. Meluch, Sarah Cannon Research Institute
Leonard A. Kalman, Memorial Sloan Kettering Cancer Center
Jeremy K. Hon
Daniel C. Scullin
Steven W. Smith, Bowling Green State University
F. Anthony Greco, Sarah Cannon Research Institute

Link

Disciplines

Publication Date

March 15, 1999

DOI

10.1002/(SICI)1097-0142(19990315)85:6<1269::AID-CNCR8>3.0.CO;2-I

Citation Information

John D. Hainsworth, Howard A. Burris, Joan B. Erland, Lisa H. Morrissey, et al.. "Phase I/II trial of paclitaxel by 1-hour infusion, carboplatin, and gemcitabine in the treatment of patients with advanced nonsmall cell lung carcinoma †" Cancer Vol. 85 Iss. 6 (1999) p. 1269 - 1276
Available at: http://works.bepress.com/leonard-kalman/15/